16.54
-1.31%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shanghai Pharmaceuticals Holding Co
Its shares trade on Shanghai under the ticker 601607.SS. It has been listed since 24 March 1994. In the fiscal year to 31 December 2025, it reported revenue of CN¥283.58bn and net income of CN¥5.72bn. At that date it held total assets of CN¥233.15bn and shareholders' equity of CN¥75.89bn.
Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai. Shanghai Pharmaceuticals Holding Co., Ltd. is a China-based company principally engaged in the manufacture and sales of pharmaceuticals. The firm's businesses include the research and registration, production, sales, distribution and retailing of pharmaceutical products, among others. Its products are applied in cardiovascular system, anti-cancer and immunoregulation, anti-infection and metabolism, as well as other fields. The firm operates businesses in domestic and overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 24 Mar 1994
- Employees
- 47,620
- Website
- sphchina.com ↗
Leadership
Pay as last reported
- Mr. Qiuhua YangExecutive Chairman of the Board, since 2024
- Mr. Bo ShenPresident, Chief Financial Officer, Executive Director, since 2010CN¥5.6m
- Mr. Yongzhong LiExecutive President, Executive Director, since 2005$6.0m
- Mr. Tao ZhongVice President, Secretary of the Board, Joint Company Secretary$3.1m
- Mr. Maimaitiaili AiliVice President
- Mr. Dongming LiVice President$3.1m
- Mr. Jianyi MaoVice President$4.0m
- Ms. Shuai ShaoVice President$2.1m
- Mr. Yong ZhaoVice President$4.5m
- Mr. Ming DongExecutive Director, since 2023
- Mr. Wenxue ZhangNon-Executive Director
- Mr. Manson FokIndependent Non-Executive DirectorCN¥300,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 74
- Environment
- 99
- Social
- 88
- Governance
- 37
- Direct emissions (scope 1)
- 84,024.45 t
- Energy emissions (scope 2)
- 295,527.33 t
- Women in the workforce
- 50.69%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shanghai Pharmaceuticals Holding Co Ltd has a strong market presence in the pharmaceutical industry, being one of the leading companies in China.
- The company has a diversified portfolio of products, including both prescription and over-the-counter drugs, which allows it to cater to a wide range of customer needs.
- Shanghai Pharmaceuticals has an extensive distribution network, ensuring efficient and timely delivery of its products to customers across China.
Weaknesses
- The company heavily relies on the domestic Chinese market, making it vulnerable to any changes in government regulations or policies that could impact the industry.
- Shanghai Pharmaceuticals faces intense competition from both domestic and international pharmaceutical companies, which puts pressure on its market share and pricing.
- The company may lack innovation and research capabilities compared to some of its competitors, limiting its ability to develop new and breakthrough drugs.
Opportunities
- With China's aging population and increasing healthcare needs, Shanghai Pharmaceuticals can capitalize on the growing demand for pharmaceutical products and services.
- Expansion into international markets presents an opportunity for the company to diversify its revenue streams and reduce dependence on the Chinese market.
- Joint ventures or strategic partnerships with research institutions or innovative companies can enhance Shanghai Pharmaceuticals' research and development capabilities.
Threats
- The emergence of counterfeit drugs in the Chinese market poses a significant threat to Shanghai Pharmaceuticals' reputation and financial performance.
- Changes in government policies, regulations, or pricing structures could impact the company's profitability and market position.
- The global economic and political uncertainties may affect the company's international expansion plans and market conditions.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.